Member Directory
Creative Places is a property consultancy helping clients to create business environments that enhance innovation and enterprise. We work throughout the UK and, as well as acting for businesses, we work for many leading hospitals, universities and government establishments.
Crescendo Biologics is building a pipeline of novel medicines based on our highly innovative VH antibody fragment platform. Crescendo’s unique transgenic mouse platform rapidly and predictably generates high-affinity human heavy chain-only antibodies using the natural process of in vivo B-cell development following immunisation. VH single domain fragments from these heavy chain-only antibodies require no humanisation, making this a rapid and reliable route to candidate quality VH therapeutics.
Software for calculating and comparing molecular field characteristics of chemical compounds and consultancy services enabling companies to outsource computational chemistry work to achieve high value, on-demand expertise, particularly in areas of library design, virtual screening, scaffold hopping, lead optimisation and patent analysis. Cresset’s field technology uses surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. This provides a smarter, structure independent way of hit-finding, lead switching and lead optimisation in drug discovery and other chemistry-based research projects.
Cushman & Wakefield are a global real estate service provider with local expertise around the world. The company have specialists advising in the Life Sciences and technology sector advising companies in how and where to set up new facilities, handling strategy, negotiation, analysis and implementation for companies from start up through to big pharma.
CW is the leading international community for companies involved in the research, development and application of wireless and mobile, internet, semiconductor and software technologies.
With an active community of over 1000 technology companies ranging from major network operators and device manufacturers to innovative start-ups and universities, CW stimulates debate and collaboration, harnesses and shares knowledge, and helps to build connections between academia and industry. Join the CW community at www.cambridgewireless.co.uk
Specialists in Science, Engineering and Technology Recruitment. CY Partners make recruitment easier for global corporations to ambitious start-ups throughout the UK and beyond. We specialise in sourcing skills and placing talent within our niche specialisms.
What we do
Whether you need to recruit staff, or find a new job, we listen, we engage and we take the time to properly understand your needs, then we look at finding a solution that is right for you.
At CY Partners, we are incredibly passionate about achieving excellence in what we do. We pride ourselves on delivering an honest and personable service for job-seekers and businesses alike. Whatever support you may need, we work with you to achieve your recruitment or job search goals.
Scientific recruitment is our core business and we’re proud to say, our customers believe we’re good at it. Since our launch in 2008, our capability has grown to provide recruitment services and advice across the Chemical, Pharmaceutical, Biotech, Life Sciences and Clinical industries. We’ve immersed ourselves in these markets and are now an integral part of this wider business community.
How do we do it?
Each member of our team is scientifically qualified in the sectors that we specialise in. This technical knowledge and industry understanding ensures that we are able to provide a service which is second to none within our marketplace.
As a business that focuses above all on quality, CY Partners are members of The Recruitment and Employment Confederation (REC) which ensures we abide by a strict code of professional practice. This means we are committed to the highest standards of conduct and compliance and work to well defined best practice guidelines.
What sets us apart?
Simply put, we quickly understand your recruitment briefs and career aspirations, and we place huge emphasis on delivering a professional and quality experience every time we engage with our customers. We are always responsive in our approach and endeavour to make the recruitment process simple, easy and ultimately successful for everyone.
We always work with integrity and strive to be a trusted and long-term partner for all our customers, so if you need to recruit or are looking for your next opportunity, we would love to hear from you.
Watch our Member Showcase video here https://bit.ly/3qny3FN
D Young & Co is a leading intellectual property firm. We are proactive, insightful and international and our Life Science team is one of the leading IP practices in Europe. Clients choose D Young & Co for IP services confident in the knowledge, experience and dedication that has characterised our work throughout our firm’s history.
DefiniGEN is a game-changing company headquartered in Cambridge, UK, with a mission to navigate drug development programs through uncertain terrain, minimizing risk while reducing costs and paving the way for a more efficient and effective future in the field of drug discovery. Our technology is revolutionizing liver models for efficacy and toxicology screening, utilizing a platform that enables the large-scale generation of hepatocyte-like cells ( Opti-Heps) with functional relevance comparable to human primary cells.
Our Opti-Heps effectively simulate crucial aspects of disease pathophysiology across various liver conditions, providing a more accurate understanding for drug development. By integrating CRISPR/Cas9 technology, DefiniGEN replicates disease phenotypes catering to unmet needs for in vitro efficacy testing and enabling the study of previously inaccessible rare monogenic liver diseases. Our Opti-Heps successfully replicate all aspects of hepatocyte pathophysiology, allowing them to replace primary liver cells in many aspects of toxicity testing. This breakthrough provides scientists with a reliable and consistent supply of highly functional hepatocytes for the first time.